The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.

about

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.

Item

http://www.wikidata.org/entity/Q47133877

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Impact of Medication Antic ...... in People With Schizophrenia.

@en

The Impact of Medication Antic ...... in People With Schizophrenia.

@nl

type

Item

label

The Impact of Medication Antic ...... in People With Schizophrenia.

@en

The Impact of Medication Antic ...... in People With Schizophrenia.

@nl

prefLabel

The Impact of Medication Antic ...... in People With Schizophrenia.

@en

The Impact of Medication Antic ...... in People With Schizophrenia.

@nl

P1476

The Impact of Medication Antic ...... in People With Schizophrenia.

@en

P2093

Attilio Rapisarda

http://www.w3.org/2001/XMLSchema#string

Jimmy Lee

http://www.w3.org/2001/XMLSchema#string

Max Lam

http://www.w3.org/2001/XMLSchema#string

Mei San Ang

http://www.w3.org/2001/XMLSchema#string

Michael Kraus

http://www.w3.org/2001/XMLSchema#string

Nur Amirah Abdul Rashid

http://www.w3.org/2001/XMLSchema#string

Richard S E Keefe

http://www.w3.org/2001/XMLSchema#string

P2860

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

Muscarinic agonists for the treatment of cognition in schizophrenia

Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Modes and models of forebrain cholinergic neuromodulation of cognition.

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Muscarinic acetylcholine receptors as CNS drug targets.

Pharmacological approaches to targeting muscarinic acetylcholine receptors.

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

A Practical Guide to Calculating Cohen's f(2), a Measure of Local Effect Size, from PROC MIXED.

P304

651-656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0000000000000790

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29016375

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

5680994

http://www.w3.org/2001/XMLSchema#string